Acumen Pharmaceuticals Inc. Gains 54.78%
Mon, Jul 17, 2023 at 07:32 PM
Acumen Pharmaceuticals Inc. (ABOS:NASDAQ) soared at $9.72, a gain of 54.8%. On Mon, Jul 17, 2023, ABOS:NASDAQ hit a New 2-Week High of $9.72. The stock appeared on our News Catalysts scanner on Mon, Jul 17, 2023 at 05:42 PM in the 'PUBLIC OFFERING' category. From Mon, Jul 03, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
About Acumen Pharmaceuticals Inc. (ABOS:NASDAQ)
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease.
Top 10 Gainers:
- ProMIS Neurosciences Inc. (PMN:NASDAQ), 120.28%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 75.85%
- Acumen Pharmaceuticals Inc. (ABOS:NASDAQ), 54.78%
- Prestige Wealth Inc. (PWM:NASDAQ), 45.67%
- GreenPower Motor Company Inc. (GP:NASDAQ), 44.25%
- Quantum-Si Incorporated (QSI:NASDAQ), 33.88%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 31.67%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 31.35%
- Kelso Technologies Inc. (KIQ:NYSEMKT), 28.86%
- argenx SE (ARGX:NASDAQ), 27.79%